[1]CurrentPatentAssignee:SANOFI-US5750550,1998,A
Title: Synthesis and SAR studies of 1,4-benzoxazine MenB inhibitors: novel antibacterial agents against Mycobacterium tuberculosis.
Journal: Bioorganic & medicinal chemistry letters 20101101
103755-57-3
1250786-93-6
1250525-78-0
145130-50-3
264208-45-9
496918-94-6
475102-11-5 | 1-BOC-4-chloroindole-2-boronic acid | AA00D7WX | MFCD04114582
5460-60-6 | N-(2-PHENYLETHYL)-PHENYLACETAMIDE | AA00D80I | MFCD00043534
543-18-0 | Guanidinoethyl sulfonate | AA00D851 | MFCD00084865
459856-12-3 | 2-Methyl-6-methoxypyridine-3-boronic acid | AA00D8B6 | MFCD05662386
50664-71-6 | CYCLOPROPYL 4-ETHYLPHENYL KETONE | AA00D8F1 | MFCD00019234
52803-60-8 | 2-[(2,4-Dichlorobenzyl)oxy]benzaldehyde | AA00D8KP | MFCD01025492
52939-33-0 | H-MePhe(4-Meo)-OH | AA00D8QX | MFCD00038797
519056-61-2 | (4-tert-butylphenyl)methanesulfonyl chloride | AA00D8VP | MFCD04115413
5319-42-6 | N-ortho-Fluorophenylglycine | AA00D91Q | MFCD00002687
462068-43-5 | 5-(tert-Butyl)-4-(hydroxymethyl)-2-methylfuran-3-carboxylic acid | AA00D998 | MFCD02737949